SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
HuMAB companies
An SI Board Since May 2000
Posts SubjectMarks Bans
1022 55 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
172I take it this is why you are asking ? <i>The Company recently announced nigel bates-5/31/2001
171No, but you might find this useful - Message 15430898nigel bates-5/31/2001
170Anyone have any idea of the range of values for the phage display market or wheraknahow-5/30/2001
169Alexion claims to have created first rationally designed antibody agonist via phkeokalani'nui-5/30/2001
168pharmalicensing.com This site is of interest as is the specific information re:aknahow-5/28/2001
167Morphosys results apparently disappointed the market, with the stock down about nigel bates-5/28/2001
166Very interesting article on Genencor's "i-mune assay", a <i>nigel bates-5/28/2001
165Message 15846490 <i>In the long-term, it is Phylos' belief that the annigel bates-5/24/2001
164PHILADELPHIA, May 23 /PRNewswire/ -- Late-breaking advances in engineered antibonigel bates-5/23/2001
163Just suggesting that the cash angle no longer has the same importance it once diaknahow-5/23/2001
162<i>In periods of low interest rates, "cash is trash".</i> nigel bates-5/23/2001
161PDLI / Exelixis collaboration - Message 15838112nigel bates-5/22/2001
160There were so many post promoting the advantages of having lots of cash, I was iaknahow-5/18/2001
159Hoppsan! - A Swedish IPO. Sweden's BioInvent to test funding waters with Icebrg-5/18/2001
158Anyone any views on why CRXL are trading at quite such a low multiple of cash ? nigel bates-5/17/2001
157REHOVOT, Israel and NEW IPSWICH, N.H., May 16 /PRNewswire/ -- XTL Biopharmaceutinigel bates-5/16/2001
156Antigen-Targeted Antibody-Based Therapies to Be Featured at Engineered Antibodienigel bates-5/15/2001
155The first deal (that I'm aware of) is struck. Eos is getting promiscuous (thnigel bates-5/8/2001
154Genmab Announces Broad Antibody Development Collaboration With Roche COPENHAGENnigel bates-5/7/2001
153Genentech Wins Patent Dispute With GlaxoSmithKline SOUTH SAN FRANCISCO, Calif.--keokalani'nui-5/4/2001
152I did primary immunizations in the SCID/hu mouse model, and couldn't get an scaram(o)uche-5/1/2001
151If this technique can go head to head with ABGX / MEDX, why would IDPH sell out nigel bates-5/1/2001
150I have seen little discussion here of AVN's mouse-to-HuMab effort, Xenerex. tuck-5/1/2001
149April 23 /PRNewswire/ -- American Biogenetic Sciences, Inc. (ABS) (Nasdaq: MABA nigel bates-4/23/2001
148Tuck, Tommysdad may have some thoughts on this. It makes since, chemically, thajayhawk969-4/17/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News